Find uplifting stories about heroes, innovations, and solutions
19230 results for "mrna technology"
A personalized cancer treatment using mRNA technology showed remarkable success in preventing melanoma from returning after surgery. This marks the first time an mRNA cancer drug has proven effective in a large, late-stage clinical trial.
Johns Hopkins researchers found a chemical tweak that makes mRNA medicines produce proteins nearly twice as fast as current COVID vaccine technology. The discovery could lead to more powerful treatments using smaller doses.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
A personalized cancer treatment using mRNA technology just passed its first large-scale trial, significantly reducing melanoma recurrence. Experts are calling it a breakthrough moment for cancer care. #
Scientists have cracked a major puzzle in malaria prevention using mRNA vaccine technology to overcome a natural barrier that weakened previous vaccines. The breakthrough could transform protection against a disease that still causes hundreds of millions of infections each year.
An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce. The same technology that powered COVID vaccines is now set to revolutionize flu prevention.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
The FDA just greenlit the first mRNA flu shot, bringing the same technology that revolutionized COVID vaccines to your annual flu protection. Adults 50 and older will soon have this new option at their pharmacy.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.
mRNA vaccines prevented eight million COVID infections in their first six months and now show promise for treating cancer. Despite recent political setbacks, scientists remain confident this breakthrough technology will transform medicine.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
A breakthrough flu vaccine using the same technology that helped end the COVID-19 pandemic just cleared a major hurdle, potentially offering faster protection for millions of seniors. The FDA's expert panel unanimously recommended approval of Moderna's mRNA flu shot for Americans over 50.
A personalized cancer vaccine using mRNA technology just helped melanoma patients live longer without their cancer returning. The breakthrough treatment could become the first of its kind approved for cancer care.
A groundbreaking mRNA therapy is helping high-risk melanoma patients stay cancer-free. The same technology that powered COVID vaccines is now opening doors to prevent deadly skin cancer from returning.
A personalized mRNA cancer vaccine has succeeded in a late-stage clinical trial for melanoma, opening the door to a new era of cancer treatment. This breakthrough could transform how doctors prevent and treat multiple types of cancer.
A new type of flu shot using mRNA technology just cleared a major hurdle, bringing us closer to better protection against seasonal flu. The same groundbreaking approach that powered COVID vaccines could soon help millions stay healthier each winter.
A personalized mRNA cancer vaccine combined with existing treatment stopped melanoma from returning in a major clinical trial. The breakthrough could open a powerful new way to fight cancer using the same technology that powered COVID vaccines.
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
Showing 20 of 19230